Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

bioMerieux resumes mycoplasma kit sales

This article was originally published in Clinica

Executive Summary

bioMerieux has restarted manufacture and sales of its Mycoplasma IST kits following a successful court appeal. The Lyon Appeals Court quashed a ruling made by the Lyon High Court last September, declaring null and void three claims of the patent infringement case brought by fellow French manufacturer International Microbio and its holding company DBV. bioMerieux told Clinica it will be seeking a refund of the Fr 900,000 ($180,000) it was ordered to pay DBV following the original court decision.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083849

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel